Jude Onyia, Ph.D.
Board Member
Voyager Therapeutics, Inc. (VYGR)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jude Onyia, Ph.D.
Jude Onyia, Ph.D. is recorded as Board Member at Voyager Therapeutics, Inc. (VYGR). Voyager Therapeutics, Inc. reported in an 8-K filed February 24, 2023 that Jude Onyia, Ph.D. was appointed director, effective February 21, 2023.
“On February 21, 2023 (the "Collaboration Effective Date"), the Board of Directors (the "Board") of Voyager Therapeutics, Inc. (the "Company"), approved the appointment of Jude Onyia, Ph.D., to serve as a director of the Company, contingent upon and effective as of the closing of the issuance and sale of 4,395,588 shares of common stock of the Company (the "Shares") to Neurocrine Biosciences, Inc.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-02-21–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Voyager Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Alfred Sandrock CEO, Board Member
- Alfred Sandrock, M.D., Ph.D. CEO, Board Member
- Michael Higgins CEO, Board Member
- Nathan Jorgensen, Ph.D., M.B.A. CFO
- Peter P. Pfreundschuh CFO
- Robin Swartz CFO, COO
- Glenn Pierce, M.D., Ph.D. CTO, Board Member
- Gregory Shiferman General Counsel
- Amy Quinlan Chief Accounting Officer
- Julie Burek Chief Accounting Officer
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.